Draftkings Inc. diskutieren
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at UBS Group AG from $56.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $47.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at JPMorgan Chase & Co. from $48.00 to $54.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings Inc. (NASDAQ: DKNG) had its price target raised by analysts at Barclays PLC from $43.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
Neueste Beiträge
StockNews_com in Ampio Pharmaceuticals Inc. diskutieren